MRVI - CIK 0001823239
The table below shows MARAVAI LIFESCIENCES HOLDINGS, INC.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$57.57M | $7.46M | $126.22M | $535.98M | $368.57M | $152.19M |
| Capital expenditure | $13.15M | $29.66M | $65.55M | $17.09M | $14.85M | $25.41M |
| Investing cash flow | -$31.41M | -$24.32M | -$122.31M | -$267.61M | $105.66M | $6.07M |
| Dividends paid | - | - | - | - | - | - |
MARAVAI LIFESCIENCES HOLDINGS, INC. reported operating cash flow of -$57.57M for fiscal year 2025. That is down 871.2% from $7.46M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from $24.11M (FY 2019) to -$57.57M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | - | - | - | $0.00 | $0.00 | $33.66M |
| Financing cash flow | -$16.50M | -$235.71M | -$61.09M | -$187.50M | -$159.05M | $53.21M |